Sarcoma Patients EuroNet established a Scientific Board with a high level of scientific expertise with the following objectives:
Support SPAEN in:
- gaining legitimacy within the European and International community of experts involved in Sarcoma, GIST and desmoïd tumours;
- ensuring patient representation and integration in major scientific committees and groups of experts at a national and international level.
Appointed members of the SPAEN Scientific Board:
| Name | Field | Country/City | Expert Group |
| Prof. Jean Yves Blay (Chair) | Oncology | France/Lyon | GSF GETO |
| Prof. Javier Martin Broto | Oncology | Spain/Sevilla | GEIS |
| Dr. Paolo Casali | Oncology | Italy/Milano | ISG |
| Prof. Jean Michel Coindre | Pathology | France/Bordeaux | GSF GETO |
| Prof. Mikael Eriksson | Oncology | Sweden/Lund | SSG |
| Dr. Alessandro Gronchi | Surgery | Italy/Milano | ISG |
| Prof. Peter Hohenberger | Surgery | Germany/Mannheim | GISG/KO.SAR |
| Mr. Craig Gerrand | Surgery | UK/Newcastle | BSG |
| PD Dr. Peter Reichardt | Oncology | Germany/Berlin | GISG |
| Prof. Piotr Rutkowski | Surgery | Poland/Warsaw | POLSG |
| Dr. Beatrice Seddon | Oncology | UK/London | BSG |
| Prof. Winette van der Graaf | Oncology | Netherlands/Amsterdam | EORTC STBSG |
| Dr. Rick Haas | Radiotherapy | Netherlands/Amsterdam | EORTC STBSG |
| Prof. Bernd Kasper | Oncology | Germany/Mannheim | EORTC STBSG |
| Dr. Robin Jones | Oncology | London/UK | BSG |
|
“Sarcoma Patients EuroNet is a very welcome development. We need to involve patients in clinical trials at the design stage so that the relevance of what we do can be considered at the outset. In addition, SPAEN will be valuable helping patients understand what being tr eated in a clinical trial could mean to them. Together we can complete research more quickly and introduce new treatments faster.” Prof. Dr. Jean Yes Blay, Chair of the SPAEN Scientific Board |